Remove Events Remove Pharmaceuticals Remove Psychedelic therapy
article thumbnail

One Person’s Journey from Celebrity Medical Model Advocate to Skeptic: An Interview with Rose Cartwright

Mad in America

Dhar: Eventually you found the trauma model that talked about extreme childhood stress events, and it explained a lot of your suffering. You write that you worry about how psychedelics are getting co-opted by pharmaceutical industries. There wasn’t much space for another way of seeing the problem of obsessions and compulsions.

article thumbnail

A Win for Science, with Profound Implications for Industry: FDA Rejects MDMA

Mad in America

L ykos Therapeutics experienced a double blow this week, with the FDA’s rejection of their proprietary MDMA-assisted therapy for PTSD and the retraction of three articles on MDMA’s supposed efficacy. Moreover, Lykos is a small company bringing it to market, one that emerged out of a psychedelic research nonprofit (MAPS).